Hormone therapy use among postmenopausal French women before the publication of the Women's Health Initiative Study: Duration of use and factors associated with discontinuation

Fertility and Sterility

Volumn 83, Issue 6, 2005, Pages 1771-1779

  Ringa, Virginie ^a   Varnoux, Noëlle ^a   Piault, Stéphanie ^a   Bréart, Gérard ^a  

^a INSERM   (France)

Author keywords

Cohort study; Duration; Hormone therapy; Menopause

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COHORT ANALYSIS; FEMALE; GYNECOLOGY; HORMONAL THERAPY; HOT FLUSH; HUMAN; MEDICAL LITERATURE; MENOPAUSE; PHYSICIAN; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; SAFETY;

CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CONFIDENCE INTERVALS; ESTROGEN REPLACEMENT THERAPY; FEMALE; FRANCE; HUMANS; MIDDLE AGED; ODDS RATIO; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; TIME FACTORS; WOMEN'S HEALTH;

EID: 20444481730     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2004.12.040     Document Type: Article

References (36)

1. H.D. Nelson Postmenopausal estrogen for treatment of hot flashes clinical applications Jama 291 2004 1621 1625
2. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the Women's Health Initiative randomized controlled trial Jama 288 2002 321 333
3. V. Beral Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427
4. I. Bjorn, T. Backstrom Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy Maturitas 32 1999 77 86
5. M. Goldberg, J.F. Chastang, A. Leclerc, M. Zins, S. Bonefant, I. Bugel Socioeconomic, demographic, occupational, and health factors associated with participation in a long-term epidemiologic survey a prospective study of the French GAZEL cohort and its target population Am J Epidemiol 154 2001 373 384
6. A. Fauconnier, V. Ringa, D. Delanoe, B. Falissard, G. Breart Use of hormone replacement therapy women's representations of menopause and beauty care practices Maturitas 35 2000 215 228
7. F.P.M.J. Groeneveld, F.P. Bareman, R. Barentsen, H.J. Dokter, A.C. Drogendijk, A.W. Hoes Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years Maturitas 20 1995 81 89
8. A. Cano Compliance to hormone replacement therapy in menopausal women controlled in a third-level academic centre Maturitas 20 1995 91 99
9. B. Karakoc, M. Erenus Compliance considerations with hormone replacement therapy Menopause 5 1998 102 106
10. T.H.K. Chung, T.K. Lau, L.P. Cheung, C.J. Haines Compliance with hormone replacement therapy in Chinese women in Hong Kong Maturitas 28 1998 213 219
11. T.N. Leung, C.J. Haines, T.K. Chung Five-year compliance with hormone replacement therapy in postmenopausal Chinese women in Hong Kong Maturitas 39 2001 195 201
12. N.I. Gavin, J.M. Thorp, R.L. Ohsfeldt Determinants of hormone replacement therapy duration among postmenopausal women with intact uteri Menopause 8 2001 377 383
13. D.R. Halbert, T. Lloyd, N. Rollings, W. Kowalski, E. Mauger Hormone replacement therapy usage a 10-year experience of a solo practitioner Maturitas 29 1998 67 73
14. C. Olesen, F.H. Steffensen, H.T. Sorensen, G.L. Nielsen, J. Olsen, U. Bergman Low use of long-term hormone replacement therapy in Denmark Br J Clin Pharmacol 47 1999 323 328
15. D.S.M. Buist, A.Z. Lacroix, K.M. Newton, N.L. Keenan Are long-term hormone replacement therapy users different from short-term and never users? Am J Epidemiol 149 1999 275 281
16. T. Vithamaki, R. Savilahti, R. Tuimala Why do postmenopausal women discontinue hormone replacement therapy? Maturitas 33 1999 99 105
17. V.L. Handa, R. Landerman, J.T. Hanlon, T. Harris, H.J. Cohen Do older women use estrogen replacement? Data from the Duke established populations for epidemiologic studies of the elderly (EPESE) J Am Geriatr Soc 44 1996 1 6
18. A.J. Isaacs, A.R. Britton, K. Mc Pherson Utilisation of hormone replacement therapy by women doctors Br Med J 311 1995 1399 1401
19. I. den Tonkelaar, B.J. Oddens Determinants of long-term hormone replacement therapy and reasons for early discontinuation Obstet Gynecol 95 2000 507 512
20. D.A. Hill, N.S. Weiss, A.Z. Lacroix Adherence to postmenopausal hormone therapy during the year after the initial prescription a population-based study Am J Obstet Gynecol 182 2000 270 276
21. P. Hee Compliance to estrogen treatment one to three years after hysterectomy and bilateral salpingooophorectomy. The cohort's lifestyle, knowledge of ERT, benefits, etc Acta Obstet Gynecol Scand 78 1999 534 539
22. G.A. Goldman, B. Kaplan, D.M. Leiserowitz, Y. Pardo, R. Amster, B. Fisch Compliance with hormone replacement therapy in postmenopausal women. A comparative study Clin Exp Obstet Gynecol 25 1998 18 19
23. A. Collins, B.-M. Landgren Psychosocial factors associated with the use of hormonal replacement therapy in a longitudinal follow-up of Swedish women Maturitas 28 1997 1 9
24. P. Eiken, N. Kolthoff Compliance with 10 years oral hormonal replacement therapy Maturitas 41 2002 81 86
25. M. Doren, G. Reuther, H.W. Minne, H.P.G. Schneider Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women Am J Obstet Gynecol 173 1995 1446 1451
26. F.W. Lafferty, M.E. Fiske Postmenopausal estrogen replacement a long-term cohort study Am J Med 97 1994 66 77
27. M. Lawrence, L. Jones, T. Lancaster, E. Daly, E. Banks Hormone replacement therapy patterns of use studied through British general practice computerized records Fam Pract 16 1999 335 342
28. R.F. Reynolds, C.M. Obermeyer, A.M. Walker, D. Guilbert Side effects and sociobehavioral factors associated with the discontinuation of hormone therapy in a Massachusetts health maintenance organization Menopause 8 2001 189 199
29. I. Persson, L. Bergkvist, C. Lindgren, J. Yuen Hormone replacement therapy and major risk factors for reproductive cancers, osteoporosis, and cardiovascular diseases evidence of confounding by exposure characteristics J Clin Epidemiol 50 1997 611 618
30. J.A. Kotzan, B.C. Martin, W.E. Wade Persistence with estrogen therapy in a postmenopausal Medicaid population Pharmacotherapy 19 1999 363 369
31. B.R. Motheral, K.A. Fairman Patient education programs and continuance with estrogen replacement therapy evaluation of the women's health exchange Menopause 5 1998 35 42
32. B. Ettinger, A. Pressman, C. Bradley Comparison of continuation of postmenopausal hormone replacement therapy transdermal versus oral estrogen Menopause 5 1998 152 156
33. M.T. Connelly, M. Richardson, R. Platt Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995 J Gen Intern Med 15 2000 542 550
34. D.L. Faulkner, C. Young, D. Hutchins, J.S. McCollam Patient noncompliance with hormone replacement therapy a nationwide estimate using a large prescription claims database Menopause 5 1998 226 229
35. D. Serfaty, P. de Reilhac, E. Eschwège, V. Ringa, P. Blin, A. Nandeuil Compliance with hormone replacement therapy in menopausal women results of a two-year prospective French study comparing transdermal treatment with fixed oral combination therapy Gynecol Obstet Fertil 31 2003 525 533
36. S.R. Sturgeon, C. Schairer, L.A. Brinton, T. Pearson, R.N. Hoover Evidence of a healthy estrogen user survivor effect Epidemiology 6 1995 227 231